Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD.
Specifically, Qualcomm Life will develop the reference design for the module that will connect the Breezhaler to the Qualcomm Life 2net platform, a hub for connecting home health devices. This platform will collect data on inhaler usage, including the duration of the patient's inhalation, which Novartis said indicates quality of the inhalation.

It is exciting to see that the Internet of Medical Things is continuously evolving and extending towards the respiratory care. MyAirCoach is also aiming in this direction and hopes to help asthma patients by introducing novel mHealth approaches for the support of asthma self-management.

Novartis, Qualcomm Life to develop connected inhaler for COPD

5 companies breathing life into the connected inhaler space